RTTNews | Nov 12, 2021 07:53AM EST

07:53 Friday, November 12, 2021 (RTTNews) - Apellis Pharma Plans To Submit NDA For Intravitreal Pegcetacoplan In The First Half Of 2022

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved